[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:solitary-fibrous-tumor":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":30,"states":31},"Solitary Fibrous Tumor",3,2,[8,16,23],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06239272","NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)",[12],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:18:06.247899Z","2026-07-19T19:36:05.068230Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT06789172","A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors",[20],"Phase 1","2026-08-26T02:16:18.872924Z","2026-07-05T05:32:16.698119Z",{"nct_id":24,"title":25,"phases":26,"status":27,"updated_at":28,"content_modified":29},"NCT07118176","Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers",[20],"ACTIVE_NOT_RECRUITING","2026-08-03T03:24:20.303158Z","2026-05-05T02:43:28.732453Z",[],[]]